Edition:
United States

Jeil Pharmaceutical Co Ltd (002620.KS)

002620.KS on Korea Stock Exchange

71,800.00KRW
28 Jul 2016
Change (% chg)

₩1,200.00 (+1.70%)
Prev Close
₩70,600.00
Open
₩70,800.00
Day's High
₩72,400.00
Day's Low
₩69,700.00
Volume
89,487
Avg. Vol
165,621
52-wk High
₩139,000.00
52-wk Low
₩18,000.00

002620.KS

Chart for 002620.KS

About

Jeil Pharmaceutical Co.,Ltd is a Korea-based company mainly engaged in the manufacture and distribution of pharmaceuticals. The Company provides antibiotics, anti-inflammatory painkillers, hepatitis remedies, duodenum ulcer treatments, anticancer drugs, tristimania drugs, gastritis drugs, stomach ulcer drugs, septicemia... (more)
No analyst recommendations are available for 002620.KS.

Overall

Beta: 0.66
Market Cap(Mil.): ₩1,048,410.00
Shares Outstanding(Mil.): 14.85
Dividend: 60.00
Yield (%): 0.08

Financials

  002620.KS Industry Sector
P/E (TTM): 85.67 36.73 37.52
EPS (TTM): 824.05 -- --
ROI: 3.88 15.28 14.48
ROE: 4.40 16.33 15.65

Earnings vs. Estimates

No consensus analysis data available.

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Wright Reports
$75.00
Provider : GlobalData
$300.00
Provider : Sadif Analytics Prime
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.